These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38849334)

  • 1. Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression.
    Kabotyanski KE; Najera RA; Banks GP; Sharma H; Provenza NR; Hayden BY; Mathew SJ; Sheth SA
    Transl Psychiatry; 2024 Jun; 14(1):243. PubMed ID: 38849334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.
    Pietzsch JB; Garner AM; Marks WJ
    Neuromodulation; 2016 Oct; 19(7):689-697. PubMed ID: 27491661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder.
    Ooms P; Blankers M; Figee M; Bergfeld IO; van den Munckhof P; Schuurman PR; Denys D
    Brain Stimul; 2017; 10(4):836-842. PubMed ID: 28457837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder.
    Najera RA; Gregory ST; Shofty B; Anand A; Gadot R; Youngerman BE; Storch EA; Goodman WK; Sheth SA
    J Neurosurg; 2023 Feb; 138(2):347-357. PubMed ID: 35907186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Deep Brain Stimulation for Parkinson Disease in Taiwan.
    Fann JC; Chang KC; Yen AM; Chen SL; Chiu SY; Chen HH; Liou HH
    World Neurosurg; 2020 Jun; 138():e459-e468. PubMed ID: 32147563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: A lifetime decision analytic model.
    Chan HY; Wijnen BFM; Majoie MHJM; Evers SMAA; Hiligsmann M
    Epilepsia; 2022 Mar; 63(3):641-651. PubMed ID: 34967942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
    Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
    Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of deep-brain stimulation for Tourette's syndrome: an initial exploration.
    Dang TTH; Rowell D; Liddle J; Coyne T; Silburn P; Connelly LB
    J Neurol; 2019 Dec; 266(12):2997-3008. PubMed ID: 31485722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
    Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
    Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States.
    Ross EL; Zivin K; Maixner DF
    JAMA Psychiatry; 2018 Jul; 75(7):713-722. PubMed ID: 29800956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal recovery associated with deep brain stimulation for treatment-resistant depression: A constructivist grounded theory study.
    Raffin Bouchal DS; Ferguson AL; Green T; McAusland L; Kiss Z; Ramasubbu R
    J Psychiatr Ment Health Nurs; 2023 Oct; 30(5):1005-1018. PubMed ID: 37002931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder.
    Moon W; Kim SN; Park S; Paek SH; Kwon JS
    Medicine (Baltimore); 2017 Jul; 96(27):e7397. PubMed ID: 28682894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis.
    Fundament T; Eldridge PR; Green AL; Whone AL; Taylor RS; Williams AC; Schuepbach WM
    PLoS One; 2016; 11(7):e0159340. PubMed ID: 27441637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.